Načítá se...
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation
BACKGROUND. The purpose of this study was to identify determinants of renal disease progression in adults with Fabry disease during treatment with agalsidase beta. METHODS. Renal function was evaluated in 151 men and 62 women from the Fabry Registry who received agalsidase beta at an average dose of...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3289896/ https://ncbi.nlm.nih.gov/pubmed/21804088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfr420 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|